Citation Impact
Citing Papers
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
2008
Breast cancer
2019 Standout
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder
2011
Tailored interventions to implement recommendations for elderly patients with depression in primary care: a study protocol for a pragmatic cluster randomised controlled trial
2014
It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.
2011
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
2014
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
2010
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective
2016
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment
2012
TNF inhibitor therapy for rheumatoid arthritis
2012
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
2007
Venlafaxine versus Mirtazapine in the??Treatment of Undifferentiated Somatoform Disorder
2008
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double‐blind, active drug–controlled study
2008
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
2013
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
2012
Sarcoidosis
2013 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
2011
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
2008
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
2008
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
2020
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
2009
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Newer Biological Agents in Rheumatoid Arthritis
2010
Rheumatoid arthritis
2010 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Ulcerative colitis
2020 Standout
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety
2015
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
2014
Targeting Toll-like receptors: emerging therapeutics?
2010
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
2008
Evidence for predictive validity of remission on long‐term outcome in rheumatoid arthritis: A systematic review
2009
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
A Randomized, Pilot Study to Assess the Efficacy and Safety of Curcumin in Patients with Active Rheumatoid Arthritis
2012 Standout
Fluoxetine versus other types of pharmacotherapy for depression
2013
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
2019
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
2014
Tailored interventions to address determinants of practice
2015 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Etanercept for the treatment of rheumatoid arthritis
2013
TNF Inhibitor Therapy for Rheumatoid Arthritis
2012
Online social media fatigue and psychological wellbeing—A study of compulsive use, fear of missing out, fatigue, anxiety and depression
2018 Standout
Etanercept for the Treatment of Rheumatoid Arthritis
2018
IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections
2018
Mechanisms of Diabetic Complications
2013 Standout
Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
2019
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
2008
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme
2020
Industry sponsorship and research outcome
2017 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Ron Pedersen being referenced
Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder
2010
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study
2008
Correlation between patient and clinician assessments of depression severity in the PREVENT study
2010
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: Results from the PREVENT study
2010
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
2012
Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
2013
Self‐reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens
2011
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
2008
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
2017
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
2007
Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release
2006
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
2018
Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy
2008
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
2006
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial
2010
The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy
2007
Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial
2007
FRI0089 Assessing maintenance of remission with reduced dose etanercept plus methotrexate, methotrexate alone, or placebo in patients with early rheumatoid arthritis who achieved remission with etanercept and methotrextate: the prize study
2013